Demographic, clinical, and cognitive characteristics of T2DM patients and healthy control subjects.*

*Data are presented as the mean ± SD unless otherwise noted; ** p<0.05.

T2DM, type 2 diabetes mellitus; BMI, body mass index; HbA1c, glycated hemoglobin; HOMA2-S%, homeostasis model assessment for insulin sensitivity; ABI, ankle-brachial index; UACR, urine albumin creatinine ratio; MMSE, Mini Mental State Exam; MoCA, Montreal Cognitive Assessment; CDT, clock drawing test; MRI, magnetic resonance imaging; SVD, small vessel disease; WMLs, white matter lesions (these were assessed in both hemispheres using the Wahlund age-related white matter changes scale [40]).

Demographic, clinical, and cognitive characteristics of T2DM patients and healthy control subjects.*